Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study.
about
Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advancesCurrent and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction.Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.
P2860
Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Elevated serum complement fact ...... : a longitudinal cohort study.
@ast
Elevated serum complement fact ...... : a longitudinal cohort study.
@en
type
label
Elevated serum complement fact ...... : a longitudinal cohort study.
@ast
Elevated serum complement fact ...... : a longitudinal cohort study.
@en
prefLabel
Elevated serum complement fact ...... : a longitudinal cohort study.
@ast
Elevated serum complement fact ...... : a longitudinal cohort study.
@en
P2093
P2860
P356
P1433
P1476
Elevated serum complement fact ...... : a longitudinal cohort study.
@en
P2093
Chunlei Wu
DaMin Huang
Haiying Zhang
Jinling Xie
Qiuyan Wang
Xiaobo Yang
P2860
P2888
P356
10.1038/SREP18713
P407
P577
2016-01-04T00:00:00Z